MTOR and chronic myelogenous leukemia, BCR-ABL1 positive: The PI3K/mTOR inhibitor BEZ235 used as a monotherapy, or in combination with Chloroquine, induced apoptosis in TKI-unresponsive primary CML patients’ cells [55].